Clinical Trial Update: A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Fruquintinib in patients with advanced non-small cell lung cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED